Senti Biosciences
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $17 | $16 | $22 | $0 |
Gross Profit | -650 | 16 | -871 | -904 |
EBITDA | -13,822 | -3,533 | -13,574 | -16,271 |
EBIT | -14,489 | -4,221 | -14,467 | -16,948 |
Net Income | -12,750 | -4,221 | -14,467 | -18,126 |
Net Change In Cash | 17 | 16 | 22 | 0 |
Free Cash Flow | -14,249 | -7,481 | -6,875 | -9,446 |
Cash | 6,463 | 8,935 | 16,420 | 12,243 |
Basic Shares | 31,144 | 30,971 | 22,483 | 26,228 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $22 | $0 | $1,978 | $4,286 |
Gross Profit | -3,615 | 1,978 | 4,286 | |
EBITDA | -57,801 | -54,875 | -61,336 | -66,709 |
EBIT | -61,438 | -60,726 | -66,765 | -70,629 |
Net Income | -61,438 | -52,790 | -71,058 | -45,791 |
Net Change In Cash | 22 | 0 | 1,978 | 4,286 |
Cost of Revenue | 1,696 | |||
Free Cash Flow | -43,640 | -41,423 | -64,433 | -76,270 |
Cash | 16,420 | 48,277 | 35,926 | 57,621 |
Basic Shares | 224,833 | 4,596 | 4,437 | 4,394 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.41 |
2026-03-31 | -$0.14 |
2025-12-31 | -$0.53 |
2025-09-30 | -$0.69 |